amoxicilina netpharmalab 500 mg cápsula
netpharmalab consulting services s.l. - amoxicilina - cápsula - 500 mg - amoxicilina tri-hidratada 574 mg - amoxicillin - genérico - duração do tratamento: curta ou média duração
amoxicilina netpharmalab 500 mg cápsula
netpharmalab consulting services s.l. - amoxicilina - cápsula - 500 mg - amoxicilina tri-hidratada 574 mg - amoxicillin - genérico - duração do tratamento: curta ou média duração
amoxicilina netpharmalab 250 mg pó para suspensão oral
netpharmalab consulting services s.l. - amoxicilina - pó para suspensão oral - 250 mg - amoxicilina tri-hidratada 295.59 mg - amoxicillin - genérico - duração do tratamento: curta ou média duração
levocetirizina labesfal 5 mg comprimido revestido por película
generis farmacêutica, s.a. - levocetirizina - comprimido revestido por película - 5 mg - levocetirizina, dicloridrato 5 mg - levocetirizine - genérico - duração do tratamento: curta ou média duração
dupixent
sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agentes para dermatite, excluindo corticosteróides - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.
cibinqo
pfizer europe ma eeig - abrocitinib - dermatite, atopic - outras preparações dermatológicas - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
adtralza
leo pharma a/s - tralokinumab - dermatite, atopic - outras preparações dermatológicas - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
desdek 1 mg/g pomada
laboratório edol - produtos farmacêuticos, s.a. - mometasona - pomada - 1 mg/g - mometasona, furoato 1 mg/g - mometasone - genérico - duração do tratamento: curta ou média duração
kepin 100 mg/2 ml solução injetável
laboratórios azevedos - indústria farmacêutica, s.a. - cetoprofeno - solução injetável - 100 mg/2 ml - cetoprofeno 50 mg/ml - ketoprofen - genérico - duração do tratamento: curta ou média duração
desdek 1 mg/g pomada
laboratório edol - produtos farmacêuticos, s.a. - mometasona - pomada - 1 mg/g - mometasona, furoato 1 mg/g - mometasone - genérico - duração do tratamento: curta ou média duração